The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Patient Barriers to and Enablers of Deprescribing: a Systematic Review
Abstract
Background Inappropriate medication use is common in the elderly and the risks associated with their use are well known. The term deprescribing has been utilised to describe the complex process that is required for the safe and effective cessation of inappropriate medications. Given the primacy of the consumer in health care, their views must be central in the development of any deprescribing process.Objectives The aim of this study was to identify barriers and enablers that may influence a patient's decision to cease a medication.Data sources A systematic search of MEDLINE, International Pharmaceutical Abstracts, EMBASE, CINAHL, Informit and Scopus was conducted and augmented with a manual search. Numerous search terms relating to withdrawal of medications and consumers' beliefs were utilised.Study eligibility criteria Articles were included if the barriers or enablers were directly patient/carer reported and related to long-term medication(s) that they were currently taking or had recently ceased.Study appraisal and synthesis methods Determination of relevance and data extraction was performed independently by two reviewers. Content analysis with coding was utilised for synthesis of results.Results Twenty-one articles met the criteria and were included in the review. Three themes, disagreement/agreement with 'appropriateness' of cessation, absence/presence of a 'process' for cessation, and negative/positive 'influences' to cease medication, were identified as both potential barriers and enablers, with 'fear' of cessation and 'dislike' of medications as a fourth barrier and enabler, respectively. The most common barrier/enabler identified was 'appropriateness' of cessation, with 15 studies identifying this as a barrier and 18 as an enabler.Conclusions and implications of key findings The decision to stop a medication by an individual is influenced by multiple competing barriers and enablers. Knowledge of these will aid in the development of a deprescribing process, particularly in approaching the topic of cessation with the patient and what process should be utilised. However, further research is required to determine if the proposed patient-centred deprescribing process will result in improved patient outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, many patients indicate they would be open to considering tapering chronic medications, including BZDs, if clinicians discussed it with them.66,67”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [66]
In the citing paper
“Although some patients will be understandably reluctant to consider tapering a medication they have been taking for a long period of time and consider helpful, others may welcome the opportunity to minimize potential adverse effects and explore more optimal ways of managing their underlying conditions.65,66”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [66]
In the citing paper
“Patients who have used BZDs for a long time may be reluctant to taper the medication due to fear of experiencing adverse effects related to discontinuation.66,151,152”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [66]
Citations
Cites
Tong, A., Sainsbury, P., & Craig, J. (2007) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzm042 · Cited by 42,509 · cited 2×
“Reporting of these criteria allows the reader to assess the quality and potential bias within the study [31].”
Qualitative research in health care: Assessing quality in qualitative research
Mays, N. (2000) · BMJ · doi:10.1136/bmj.320.7226.50 · Cited by 3,742
Hesse, B. W., Nelson, D. E., Kreps, G. L., Croyle, R. T., Arora, N. K., Rimer, B. K., & Viswanath, K. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.22.2618 · Cited by 1,523 · cited 1×
“This may be due to the studies being conducted many years previous when Internet was less ubiquitous, or the majority of participants in the studies being elderly who are not as Internet-literate (and less trusting of the Internet) as the younger population, and report that they still prefer to get a majority of their…”
BackgroundGuidance on the conduct of narrative synthesis in sytematic reviews
Popay, J., Roberts, H. M., Sowden, A. J., Petticrew, M. P., Arai, L., Rodgers, M., & Britten, N. (2006) · Cited by 1,363
How can systematic reviews incorporate qualitative research? A critical perspective
Dixon-Woods, M., Bonas, S., Booth, A., Jones, D. R., Miller, T., Sutton, A. J., Shaw, R. L., Smith, J. A., & Young, B. (2006) · Qualitative Research · doi:10.1177/1468794106058867 · Cited by 860 · cited 2×
“tative studies is not appropriate [28, 30].”
MethodBannister, S. J. (2009) · Cited by 751
Potentially Inappropriate Medication Use Among Elderly Home Care Patients in Europe
Fialová, D. (2005) · JAMA · doi:10.1001/jama.293.11.1348 · Cited by 707
Polypharmacy and Prescribing Quality in Older People
Steinman, M. A., Seth Landefeld, C., Rosenthal, G. E., Berthenthal, D., Sen, S., & Kaboli, P. J. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00889.x · Cited by 537 · cited 3×
“Around 20–60 % of elderly patients are taking at least one potentially inappropriate medication (PIM), defined as a medication where the potential risks associated with use outweigh the potential benefits [1–4].”
BackgroundInappropriate Prescribing: Criteria, Detection and Prevention
OʼConnor, M. N., Gallagher, P., & OʼMahony, D. (2012) · Drugs & Aging · doi:10.2165/11632610-000000000-00000 · Cited by 351
Medication Withdrawal Trials in People Aged 65 Years and Older: A Systematic Review
Iyer, S., Naganathan, V., McLachlan, A. J., & Le Couteur, D. G. (2008) · Drugs & Aging · doi:10.2165/0002512-200825120-00004 · Cited by 339 · cited 4×
“The percentages of patients who have to restart medications due to return of condition are unknown for most medication classes, and the risk of a condition returning in an individual patient cannot be predicted [13].”
BackgroundInfluential
Cited by
Reducing Inappropriate Polypharmacy: The Process of Deprescribing
Scott, I. A., Hilmer, S. N., Reeve, E., Potter, K., Le Couteur, D., Rigby, D., Gnjidic, D., Del Mar, C. B., Roughead, E. E., Page, A., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.0324 · Cited by 1,584
Self-citationSkou, S. T., Mair, F. S., Fortin, M., Guthrie, B., Nunes, B. P., Miranda, J. J., Boyd, C. M., Pati, S., Mtenga, S., & Smith, S. M. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00376-4 · Cited by 1,362
“Chan School of Public Health (BLSCHP-1902), Bloomberg Philanthropies (via University of North Carolina at Chapel Hill School of Public Health), FONDECYT via CIENCIACTIVA/CONCYTEC, British Council, British Embassy and the NewtonPaulet Fund (223-2018, 224-2018), DFID/ MRC/Wellcome Global Health Trials (MR/M007405/1), Fo…”
MethodReeve, E., Gnjidic, D., Long, J., & Hilmer, S. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12732 · Cited by 855
Self-citationAnderson, K., Stowasser, D., Freeman, C., & Scott, I. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-006544 · Cited by 725
Page, A. T., Clifford, R. M., Potter, K., Schwartz, D., & Etherton‐Beer, C. D. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12975 · Cited by 496
Metadata
- Authors
- Reeve, E., To, J., Hendrix, I., Shakib, S., Roberts, M. S., & Wiese, M. D.
- Affiliations
- University of South Australia (AU)
- Repatriation General Hospital (AU)
- Royal Adelaide Hospital (AU)
- The University of Queensland (AU)
- Corresponding author
- Reeve, Emily
- Venue
- Drugs & Aging
- Published
- 2013-08-03
- Volume
- 30
- Issue
- 10
- Pages
- 793-807
- ISSN
- 1170-229X (ISSN-L)
- 1179-1969
- OpenAlex
- W2085842968
- Cited by
- 536
- References
- 72
- Citations by year
- 2026: 25 · 2025: 40 · 2024: 67 · 2023: 36 · 2022: 57 · 2021: 58 · 2020: 59 · 2019: 57 · 2018: 49 · 2017: 29 · 2016: 34 · 2015: 15 · 2014: 10
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Drugs & Aging (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- UniSA Research Outputs Repository (University of South Australia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Keywords
- deprescribing, inappropriate medication use, older adults, patient barriers, patient beliefs, patient-centered care, long-term medication
- MeSH terms
- Decision Making, Humans, Withholding Treatment, Inappropriate Prescribing, Patient Safety
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patient Barriers to and Enablers of Deprescribing: a Systematic Review. https://app.cochat.ai/papers/10.1007/s40266-013-0106-8
- The paper
- Reeve, E., To, J., Hendrix, I., Shakib, S., Roberts, M. S., & Wiese, M. D. (2013). Patient Barriers to and Enablers of Deprescribing: a Systematic Review. Drugs & Aging. https://doi.org/10.1007/s40266-013-0106-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.